Davide Leone & Partners Investment CO Ltd. Vertex Pharmaceuticals Inc Transaction History

Davide Leone & Partners Investment CO Ltd.

$0
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$199.77 - $247.81 $24.8 Million - $30.8 Million	-124,358 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$166.71 - $223.91 $7.97 Million - $10.7 Million	47,800 Added 62.44%	124,358 $27.2 Million
Q3 2019 Nov 14, 2019	BUY	$166.23 - $187.09 $12.7 Million - $14.3 Million	76,558 New	76,558 $13 Million

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

Capital World Investors Los Angeles, CA

26.8M
Shares

$11 Billion
1.99% of portfolio
Vanguard Group Inc Valley Forge, PA

23.2M
Shares

$9.47 Billion
0.2% of portfolio
Black Rock Inc. New York, NY

21.3M
Shares

$8.71 Billion
0.23% of portfolio
State Street Corp Boston, MA

11.8M
Shares

$4.83 Billion
0.23% of portfolio
Capital Research Global Investors Los Angeles, CA

9M
Shares

$3.68 Billion
0.9% of portfolio

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Davide Leone & Partners Investment CO Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Davide Leone & Partners Investment CO Ltd. with notifications on news.

Account